Peritoneal fluid and serum levels of hepatocyte growth factor may predict the activity of endometriosis. 2006

Khaleque Newaz Khan, and Hideaki Masuzaki, and Akira Fujishita, and Michio Kitajima, and Koichi Hiraki, and Seiyou Miura, and Ichiro Sekine, and Tadayuki Ishimaru
Department of Obstetrics and Gynecology, Nagasaki University School of Medicine, Nagasaki Minicipal Hospital, Japan. nemokhan@net.nagasaki-u.ac.jp

BACKGROUND The suitable parameter in PF as well as in serum that may predict the activity of endometriosis is not well described. Therefore, we tried to examine the peritoneal fluid (PF) and serum concentrations of hepatocyte growth factor (HGF) in different revised American Society of Reproductive Medicine (r-ASRM) staging and morphologic appearances of endometriosis in an attempt to determine whether HGF can be clinically useful to predict the activity of pelvic endometriosis. METHODS Peritoneal fluid was collected from 137 women with endometriosis and 57 women without endometriosis during laparoscopy and blood sampling was collected from 37 women with endometriosis and 21 women without endometriosis before laparoscopy. The concentration of HGF in PF and serum was measured by enzyme-linked immunosorbent assay. The ability of isolated macrophages and stroma to secrete HGF in response to lipopolysaccharide (LPS) was evaluated. RESULTS A significantly increased concentration of HGF in PF was found in women with endometriosis (1451.75 +/- 90.7 pg/mL) than that in non-endometriosis (1120.5 +/- 77.3 pg/mL, p < 0.01) without any remarkable difference in HGF levels between women with stage I-/II endometriosis and stage III-/IV endometriosis. When we distributed serum and PF levels of HGF according to different color appearances of endometriosis, we found a significantly higher serum and PF levels of HGF in women containing dominant red peritoneal lesions in pelvic cavity (740 +/- 109.3 pg/mL for serum; 1685 +/- 183.4 pg/mL for PF) than those having other pigmented lesions (649 +/- 79.5 pg/mL, p < 0.05 for serum; 1224 +/- 67.8 pg/mL, p < 0.05 for PF) or chocolate cysts (485 +/- 43.1 pg/mL, p < 0.05 for serum; 1118 +/- 83.1 pg/mL, p < 0.01 for PF). Exogenous stimulation with LPS significantly increased the production of HGF in the culture media by macrophages and stroma derived from women with endometriosis than that in women without endometriosis. CONCLUSIONS These results suggest that women with early or advanced endometriosis as measured by r-ASRM scoring system are not associated with an increase in either serum or PF concentrations of HGF. Rather HGF levels in serum and PF were significantly increased in women harboring blood-filled red peritoneal lesions and may be clinically useful to predict the activity of pelvic endometriosis.

UI MeSH Term Description Entries
D010537 Peritoneum A membrane of squamous EPITHELIAL CELLS, the mesothelial cells, covered by apical MICROVILLI that allow rapid absorption of fluid and particles in the PERITONEAL CAVITY. The peritoneum is divided into parietal and visceral components. The parietal peritoneum covers the inside of the ABDOMINAL WALL. The visceral peritoneum covers the intraperitoneal organs. The double-layered peritoneum forms the MESENTERY that suspends these organs from the abdominal wall. Parietal Peritoneum,Peritoneum, Parietal,Peritoneum, Visceral,Visceral Peritoneum,Parametrium,Parametriums
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D004715 Endometriosis A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum. Endometrioma,Endometriomas,Endometrioses
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001202 Ascitic Fluid The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY. Peritoneal Effusion,Peritoneal Fluid,Ascitic Fluids,Effusion, Peritoneal,Fluid, Ascitic,Fluid, Peritoneal,Peritoneal Effusions,Peritoneal Fluids
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity

Related Publications

Khaleque Newaz Khan, and Hideaki Masuzaki, and Akira Fujishita, and Michio Kitajima, and Koichi Hiraki, and Seiyou Miura, and Ichiro Sekine, and Tadayuki Ishimaru
January 2014, Clinical and experimental obstetrics & gynecology,
Khaleque Newaz Khan, and Hideaki Masuzaki, and Akira Fujishita, and Michio Kitajima, and Koichi Hiraki, and Seiyou Miura, and Ichiro Sekine, and Tadayuki Ishimaru
July 2013, International journal of fertility & sterility,
Khaleque Newaz Khan, and Hideaki Masuzaki, and Akira Fujishita, and Michio Kitajima, and Koichi Hiraki, and Seiyou Miura, and Ichiro Sekine, and Tadayuki Ishimaru
January 1996, The American journal of gastroenterology,
Khaleque Newaz Khan, and Hideaki Masuzaki, and Akira Fujishita, and Michio Kitajima, and Koichi Hiraki, and Seiyou Miura, and Ichiro Sekine, and Tadayuki Ishimaru
June 1999, Human reproduction (Oxford, England),
Khaleque Newaz Khan, and Hideaki Masuzaki, and Akira Fujishita, and Michio Kitajima, and Koichi Hiraki, and Seiyou Miura, and Ichiro Sekine, and Tadayuki Ishimaru
September 1995, American journal of obstetrics and gynecology,
Khaleque Newaz Khan, and Hideaki Masuzaki, and Akira Fujishita, and Michio Kitajima, and Koichi Hiraki, and Seiyou Miura, and Ichiro Sekine, and Tadayuki Ishimaru
January 1996, Hepato-gastroenterology,
Khaleque Newaz Khan, and Hideaki Masuzaki, and Akira Fujishita, and Michio Kitajima, and Koichi Hiraki, and Seiyou Miura, and Ichiro Sekine, and Tadayuki Ishimaru
October 2007, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
Khaleque Newaz Khan, and Hideaki Masuzaki, and Akira Fujishita, and Michio Kitajima, and Koichi Hiraki, and Seiyou Miura, and Ichiro Sekine, and Tadayuki Ishimaru
September 1988, Fertility and sterility,
Khaleque Newaz Khan, and Hideaki Masuzaki, and Akira Fujishita, and Michio Kitajima, and Koichi Hiraki, and Seiyou Miura, and Ichiro Sekine, and Tadayuki Ishimaru
February 1990, Fertility and sterility,
Khaleque Newaz Khan, and Hideaki Masuzaki, and Akira Fujishita, and Michio Kitajima, and Koichi Hiraki, and Seiyou Miura, and Ichiro Sekine, and Tadayuki Ishimaru
July 2019, Translational oncology,
Copied contents to your clipboard!